News

Osteomyelitis a debilitating bone infection most frequently caused by Staphylococcus aureus bacteria is particularly challenging to treat. Now, Vanderbilt microbiologist Eric Skaar, PhD, MPH, and colleagues have identified a staph-killing compound that may be an effective treatment for osteomyelitis, and they have developed a new mouse model that will be useful for testing this compound and for generating additional therapeutic strategies.